tradingkey.logo

Clinuvel Pharmaceuticals Preparing Upgrade Of ADR Program To Level II, Nasdaq Uplist

ReutersAug 22, 2025 2:08 AM

- Clinuvel Pharmaceuticals Ltd CUV.AX:

  • PREPARING UPGRADE OF ADR PROGRAM TO LEVEL II, NASDAQ UPLIST

  • PRIMARY LISTING ON ASX WILL REMAIN UNCHANGED

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI